Is Recursion Pharmaceuticals, Inc. (RXRX) a Buy, Sell, or Hold?
Recursion Pharmaceuticals, Inc.
NASDAQ:RXRX
$3.31 USD
-$0.03 (-0.9%)
- Volume
- 19.26M
- Average Volume
- 19.03M
- Market Capitalization
- $1.48B
- P/E Ratio
- -2.76
- Dividend Yield
- 0.00%
- Price Target
- $5.50
- Year High
- $7.18
- Year Low
- $2.77
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.47
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
0.13%
Investors Holding
21
change: -329 | last: 350
Increased Positions
7
change: -183 | last: 190
Reduced Positions
7
change: -78 | last: 85
New Positions
2
change: -58 | last: 60
Sold Positions
319
change: 261 | last: 58
Total Calls
298
Total Puts
-
Put-Call Ratio
0.00
change: -64.1561 | last: 0.6416
Total Invested
2.47M
RXRX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $4.09 | 447.45M | $1.83B | $743.29M | $77.96M | $1.16B |
| 2024-12-31 | $6.76 | 274.21M | $1.85B | $594.35M | $108.49M | $1.37B |
| 2023-12-31 | $9.86 | 207.85M | $2.05B | $391.56M | $50.67M | $1.71B |
| 2022-12-31 | $7.71 | 175.54M | $1.35B | $549.91M | $51M | $854.49M |
| 2021-12-31 | $17.13 | 170.27M | $2.92B | $285.12M | $11.48M | $2.64B |
| 2020-12-31 | $18.00 | 165.79M | $2.98B | $262.13M | $15.66M | $2.74B |
| 2019-12-31 | $18.00 | 165.79M | $2.98B | $69.88M | $16.17M | $2.93B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3.07 | 529.3M | $1.62B | $654.47M | $72.38M | $1.04B |
| 2025-12-31 | $4.09 | 526.72M | $2.15B | $743.29M | $77.96M | $1.49B |
| 2025-09-30 | $4.88 | 446.99M | $2.18B | $659.84M | $82.37M | $1.6B |
| 2025-06-30 | $5.06 | 417.36M | $2.11B | $528.22M | $88.08M | $1.67B |
| 2025-03-31 | $5.29 | 402.77M | $2.13B | $500.45M | $92.91M | $1.72B |
| 2024-12-31 | $6.76 | 336.04M | $2.27B | $594.35M | $108.49M | $1.79B |
| 2024-09-30 | $6.59 | 282.58M | $1.86B | $427.65M | $90.62M | $1.53B |
| 2024-06-30 | $7.46 | 242.2M | $1.81B | $474.34M | $89.88M | $1.42B |
| 2024-03-31 | $9.37 | 236.02M | $2.21B | $299.52M | $50.97M | $1.96B |
| 2023-12-31 | $9.86 | 233.16M | $2.3B | $391.56M | $50.67M | $1.96B |
| 2023-09-30 | $7.65 | 214.33M | $1.64B | $387.32M | $51.48M | $1.3B |
| 2023-06-30 | $7.47 | 201.42M | $1.5B | $405.87M | $52.9M | $1.15B |